Pharma POOL
Robert H. Armstrong
Dr. Steven Caffe
Baxter Names VPs
Baxter International, a healthcare company in Deerfield, Ill., has appointed Robert H. Armstrong to the newly created position of VP, research and development, medical devices and adjacent disposables. He is responsible for developing a new R&D Device Center of Excellence. Before joining Baxter, Mr. Armstrong spent more than 20 years at GE Healthcare, most recently as general manager of R&D for CT products, positron emission technology, and nuclear medicine. He has an MBA from the University of Wisconsin, Milwaukee, and a B.S. in physics from St. Norbert College. Baxter also has hired Steven Caffe, M.D., as VP of global regulatory affairs and medical vigilance. Dr. Caffe most recently served as U.S. deputy head of regulatory development at Sanofi-Aventis. He earned his M.D. from the Universite Pierre et Marie Curie in Paris. Dr. Sol J. Barer Robert J. Hugin Celgene Plans Transition Sol J. Barer, Ph.D., has been named CEO of Celgene, Summit, N.J., an integrated pharmaceutical company. Dr. Barer will succeed John W. Jackson on May 1, 2006. Mr. Jackson will remain chairman of Celgene’s board of directors. Dr. Barer has been a member of the Celgene leadership team since its incorporation in 1986. He has served as president and chief operating officer since 1994. He holds a Ph.D. in organic and physical chemistry from Rutgers University. Additionally, Celgene has appointed Robert J. Hugin to president and chief operating officer. He also assumes his new position on May 1, 2006. Mr. Hugin joined Celgene in 1999 as senior VP and chief financial officer. He has an A.B. from Princeton University and an MBA from the University of Virginia. Dr. Joseph S. Barone Dr. Laurence Downey Solvay Hires and Promotes Joseph S. Barone, M.D., has been named VP of drug safety and surveillance for Solvay Pharmaceuticals, Marietta, Ga., a research-driven pharmaceutical company. In addition to leading the U.S. drug safety and surveillance department, Dr. Barone oversees and directs all postmarketing adverse event collection, evaluation, and reporting activities. Most recently, he was employed by Daiichi Medical Research. He has a medical degree from Cornell University Medical College. Additionally, Laurence Downey, M.D., has been named president and CEO. He succeeds Harold H. Shlevin, Ph.D., who has taken on a position of global responsibility within the Solvay Group. A 25-year veteran of the company, Dr. Downey most recently served as president and CEO of Solvay Pharma in Canada. He has a medical degree from the University of Manchester and a diploma in pharmaceutical medicine from the Royal College of Physicians. Dr. Sef Kurstjens Astellas Appoints U.S. R&D Head Sef Kurstjens, M.D., Ph.D., has been named senior VP of research and development at Astellas Pharma US, Deerfield, Ill., a research-based pharmaceutical company and a subsidiary of Tokyo-based Astellas Pharma. In this role, Dr. Kurstjens oversees the company’s U.S.-based product development efforts. He previously held positions of increasing responsibility at Pfizer Global Research and Development in both Europe and the United States. Dr. Kurstjens has advanced degrees in medicine and experimental physiology from University of the Witwatersrand Medical School in Johannesburg. Dean Slack King Builds Team King Pharmaceuticals has appointed Dean Slack as VP of business development and strategy for its international and strategic marketing research department. Based in Bristol, Tenn., King is a vertically integrated branded pharmaceutical company. Mr. Slack was previously employed at GlaxoSmithKline. He holds an MBA from Duke University’s Fuqua School of Business and a bachelor’s degree in new venture management from Ohio State University. Biotech POOL William C. Bertrand Jr. Dr. Genevieve Losonsky Anthony Luttrell Dr. Frank J. Malinoski Dr. Robert Walker Dr. John J. Whalen MedImmune Expands Management Team MedImmune, a biotechnology company in Gaithersburg, Md., has expanded its management team. William C. Bertrand Jr., has been promoted to senior VP, general counsel, secretary, and corporate compliance officer. Mr. Bertrand has held positions of increasing responsibility in MedImmune’s legal affairs department since 2001. He has a B.S. in biology from Wayne State University and a J.D., cum laude, from University of Wisconsin, Madison. MedImmune also has promoted Genevieve Losonsky, M.D., to VP of clinical development, infectious disease. Since joining the company in 2002, Dr. Losonsky has served as project director for several clinical programs involving MedImmune’s respiratory syncytial virus prevention franchise. Previously, she was an associate professor in the Department of Pediatrics and Medicine at the University of Maryland School of Medicine. She has a bachelor’s degree in biology and psychology from New York University and an M.D. from the State University of New York at Buffalo. Anthony Luttrell has been hired as VP of quality. Responsible for the strategic direction of MedImmune’s quality organization, he oversees the quality assurance, quality control, compliance, validation, and clinical quality departments. Mr. Luttrell began consulting with MedImmune in 2000. He has a bachelor’s degree in biology from Spring Arbor College, an MBA from Oakland University, and a certification from the Minnesota Executive Development Program of the Carlson School of Business at the University of Minnesota. Frank J. Malinoski, M.D., Ph.D., has joined the company as VP of medical affairs, infectious disease. Most recently, Dr. Malinoski served as president of his own consulting practice, TD Consultancy. He has a bachelor’s degree in biology from Colby College, a Ph.D. in microbiology from Rutgers University, and an M.D. from Albany Medical College. Robert Walker, M.D., has been promoted to VP of clinical development, inflammatory disease. He oversees clinical trials of new product candidates aimed at preventing or treating various autoimmune and pulmonary diseases. He previously was project director for MedImmune’s intranasal influenza vaccine program and continues to be the senior project lead for that program. He has a B.A. from Vassar College and an M.D. from the University of Maryland School of Medicine. John J. Whalen, M.D., has joined MedImmune as VP of clinical development operations. Dr. Whalen most recently worked for Scirex as general manager of clinical development services. He has a B.S. in physics from Rensselaer Polytechnic Institute and an M.D. from the University of Virginia Medical School. Ian T. Clark Jennifer Cook Dr. Ashraf Hanna Dr. Ann L. Lee Quinton C. Oswald Robert S. Quinn Dr. Patrick Yang Genentech Hires and Promotes Genentech, a biotechnology company with headquarters in South San Francisco, Calif., has promoted Ian T. Clark, to executive VP. He previously was senior VP of commercial operations. In this new role, he leads Genentech’s commercial operations, including sales, marketing, managed care, commercial development, and commercial operations functions. He joined the company in January 2003 as senior VP and general manager of bio-oncology. Jennifer Cook, 40, has been promoted to the newly created position of VP of market development, responsible for managing market planning, forecasting and business analysis, pricing and publication strategy, international operations, and commercial communications. She most recently served as senior director of market development. Ms. Cook has a B.A. in human biology and an M.S. in biology from Stanford University. She also has an MBA from the University of California, Berkeley. Ashraf Hanna, M.D., Ph.D., has been hired to the newly created position of VP of alliance management and pipeline strategy support, responsible for establishing, implementing, and evaluating alliance-management strategies and processes. Dr. Hanna was most recently VP of Tanox with responsibilities for strategic planning and business development. Dr. Hanna has a B.A. in physics from the University of Chicago, a Ph.D. in physics from Harvard University, and an M.D. from the University of Massachusetts Medical School. Ann L. Lee, Ph.D., has joined Genentech as VP of process development, responsible for the development, implementation, and support of clinical and commercial production processes and technologies. Dr. Lee joins Genentech from Merck, where she most recently served as VP of chemical technology and engineering in the manufacturing division. In addition to a B.S. in chemical engineering from Cornell University, she earned an M.S. in chemical engineering and a Ph.D. in engineering and applied sciences from Yale University. Quinton C. Oswald has joined Genentech as VP of sales and marketing, tissue growth and repair. In this newly created position, he is responsible for sales and marketing for Lucentis, Lytics, Nutropin, and Pulmozyme. Mr. Oswald previously was senior VP of Novartis Ophthalmics North America. Genentech has appointed Robert S. Quinn as VP of corporate information technology (CIT), business and science applications. He focuses on a variety of IT solutions to support the corporate and commercial functions, as well as research and development. Mr. Quinn comes to Genentech from KLA-Tencor, where he was VP and chief information officer. He has B.A. degrees in economics and accounting from Baldwin-Wallace College. Patrick Yang, Ph.D., has been promoted to executive VP of product operations from senior VP of product operations. He is responsible for the company’s manufacturing, engineering, process development, and supply-chain management organizations. Dr. Yang began his career at Genentech in December 2003 as VP of South San Francisco manufacturing and engineering. Dr. Steven I. Engel Boston Life Sciences Names Senior VP Boston Life Sciences, Hopkintown, Mass., a biotechnology company focused on diagnostic and therapeutic products for central nervous system diseases, has appointed Steven I. Engel, Pharm.D., senior VP of regulatory affairs and quality. Most recently, Dr. Engel was VP of regulatory affairs and quality at AlgoRx. He has an M.S. from the University of North Carolina at Chapel Hill and a Pharm.D. from the University of Florida. Dr. Elliot Goldstein Grant Yonehiro Maxygen Makes Management Changes Maxygen, a biotechnology company based in Redwood City, Calif., has appointed Elliot Goldstein, M.D., chief operating officer. He has been promoted from senior VP of clinical development and Denmark operations, the position he had held since joining Maxygen in February 2003. He has an M.D. from the University of Aix-Marseille. Grant Yonehiro has been promoted to senior VP, responsible for leading U.S. operations and global business development, from his previous position as VP of business development. He has a B.I.S. from the University of Minnesota and an MBA from the Walter A. Haas School of Business, Berkeley. Donna Jordan Biovest Names VP Donna Jordan has joined Biovest International as VP of quality control and quality assurance. Based in Worcester, Mass., Biovest develops advanced, individualized immunotherapies for life-threatening cancers of the blood system. Most recently, Ms. Jordan was director of quality systems at RenaMed Biologics. Dr. Robert W. Karr Idera Appoints President Idera Pharmaceuticals, a biotechnology company in Cambridge, Mass., has appointed Robert W. Karr, M.D., as president. Dr. Karr has served on the company’s board of directors since June 2005. He previously was a senior VP of strategic management at Pfizer Global Research and Development. Dr. Karr earned his M.D. from the University of Texas Medical Branch at Galveston. Dr. G. Allen Nickols Pfizer Veteran Joins Kereos Kereos, St. Louis, a biotechnology company focused on the detection and treatment of cancer, has hired G. Allen Nickols, Ph.D., as VP of biology. He most recently was director of pharmacology and science fellow at Pfizer Global Research & Development. He holds a Ph.D. in pharmacology from the University of Missouri and is a fellow of the American Heart Association. Martin A. Simonetti VLST Appoints CEO VLST, a Seattle-based biotechnology company focused on therapeutics for autoimmune and inflammatory disorders, has appointed Martin A. Simonetti as president and CEO. Mr. Simonetti brings more than 25 years of biotechnology experience to VLST, most recently as senior VP, chief financial officer, and treasurer of Dendreon. Mr. Simonetti holds an M.S. in nutritional sciences from the University of California, Davis, and an MBA from the University of Santa Clara. Biopharmaceutical POOL Cheryl Anderson ImClone Names VP ImClone Systems, New York, a biopharmaceutical company dedicated to developing oncology treatments, has appointed Cheryl Anderson as VP of regulatory affairs. Ms. Anderson previously served as group director of global oncology regulatory sciences for Bristol-Myers Squibb. She has a B.S. in biochemistry from Southern Connecticut State University. Dr. Gregory I. Berk Fred Vitale Hana Biosciences Strengthens Management Team Hana Biosciences, South San Francisco, Calif., a biopharmaceutical company focused on advancing cancer care, has promoted Gregory I. Berk, M.D, to senior VP and chief medical officer. In this role, Dr. Berk assumes overall leadership of the company’s development pipeline. He had served as VP and chief medical officer since October 2004. He received an M.D. from Case Western Reserve University School of Medicine and a B.S. from Tulane University. Hana has promoted Fred Vitale to VP and chief business officer. In addition to business development, Mr. Vitale has overall leadership of the company’s commercialization efforts of Zensana. He most recently served as Hana’s VP of business development. He has a B.S. in biology from The Citadel and a physician assistant degree from the Medical University of South Carolina. Scott Myers DOV Appoints Senior VP Scott Myers has been appointed senior VP of strategic marketing and commercialization at DOV Pharmaceutical, Hackensack, N.J., a biopharmaceutical company focused on central nervous system disorders. In addition to attracting potential development and commercialization partners, Mr. Myers is responsible for establishing the company’s business intelligence and strategic marketing units. Most recently, he was general manager of McNeil Specialty Pharmaceuticals. He has a B.A. in biology from Northwestern University and an MBA in finance and international business from the University of Chicago. Dr. Atul C. Pande CeNeRx Appoints Chief Medical Officer CeNeRx BioPharma, Cary, N.C., a start-up biopharmaceutical company focused on developing therapeutics for central nervous system disorders, has appointed Atul C. Pande, M.D., as chief medical officer. Dr. Pande is responsible for building the company’s product portfolio and leading its research and development program. He most recently served as VP and neurosciences development leader at Pfizer. Dr. Steve Worland Anadys Promotes Executive Anadys Pharmaceuticals, a San Diego-based biopharmaceutical company developing treatments for hepatitis, other serious infections, and cancer, has promoted Steve Worland, Ph.D., to executive VP of pharmaceuticals. In this role, he is responsible for strategic planning and corporate development while continuing to lead Anadys’ R&D efforts. Dr. Worland most recently served as executive VP of research and development. He originally joined Anadys as chief scientific officer in 2001. He holds a B.S. in biological chemistry from the University of Michigan and a Ph.D. in chemistry from the University of California, Berkeley. Specialty POOL David Argento William Renzo Bradley Pharmaceuticals Adds Executives Bradley Pharmaceuticals, a specialty pharmaceutical company in Fairfield, N.J., has hired David Argento as director, trade relations. In this position, he manages all of the company’s interactions with drug-distribution wholesalers and chains. Mr. Argento most recently was director of trade for Bayer Healthcare. Additionally, Bradley has hired William Renzo as VP of trade/managed-care relations. He has the overall responsibility for the trade-relations, managed-care, and international marketing departments. Dr. Diane Cooper Healthpoint Hires Director of Clinical Affairs Diane Cooper, Ph.D., has been appointed director of clinical affairs for tissue management at Healthpoint, Fort Worth, Texas, a specialty pharmaceutical company and affiliate of DFB Pharmaceuticals. She previously served as the worldwide medical director for Johnson & Johnson Wound Management, Ethicon. Dr. Cooper has a B.S. in nursing from Seattle University; a B.A. in biology from Holy Names College; a master of nursing degree in physiological nursing from the University of Washington; and a Ph.D. in nursing, with an emphasis in wound healing, from the University of Pennsylvania. Dr. Barry Flannelly Abraxis Names Global VP Barry Flannelly, Pharm.D., has been appointed to the newly created position of global VP of sales and marketing at Abraxis Oncology, the proprietary drug sales and marketing division of American Pharmaceutical Partners (APP), Schaumburg, Ill. Most recently, Dr. Flannelly, 48, was the global brand leader at Novartis Oncology for the breast cancer drug Femara. He has a Pharm.D. from the University of Maryland’s School of Pharmacy, an MBA from the University of Baltimore, and a B.S. in pharmacy from the Massachusetts College of Pharmacy. Timothy J. McIntyre Vyteris Names CEO Vyteris Holdings, Fair Lawn, N.J., has named Timothy J. McIntyre as CEO. Vyteris is a specialty pharmaceutical company developing products based upon its advanced drug-delivery technology. Mr. McIntyre previously served as partner, managing member, of CMS-Health. He received his B.A. from the University of Notre Dame. Mark W. Salyer BioDelivery Sciences Names Head of Sales and Marketing BioDelivery Sciences International (BDSI), a specialty biopharmaceutical company based in Morrisville, N.C., has appointed Mark W. Salyer to the newly created position of executive VP of sales and marketing. Mr. Salyer is responsible for designing the commercial strategy around BDSI’s proposed products and formulations. He was most recently employed by Altana Pharma as senior VP of U.S. sales and marketing and corporate VP of global franchise management, respiratory. A certified public accountant, Mr. Salyer has a B.S. in accounting from Virginia Tech and an MBA from Duke University’s Fuqua School of Business. Dr. Matthew A. Wikler Mpex Names Chief Medical Officer Mpex Pharmaceuticals, a San Diego-based company focused on the discovery and development of new antibacterial drugs, has hired Matthew A. Wikler, M.D., as chief medical officer. He most recently was the chief medical officer and executive VP at Peninsula Pharmaceuticals. He has a B.A. from Franklin and Marshall College, an M.D. from Temple University, and an MBA from the Wharton School of Business at the University of Pennsylvania. Discovery POOL Dr. John Ransom Cytori Names VP, Research Cytori Therapeutics has appointed John Ransom, Ph.D., to VP of research, regenerative cell technology, responsible for directing the company’s adipose stem and regenerative cell therapy discovery efforts. San Diego-based Cytori discovers and develops proprietary, cell-based therapeutics. Dr. Ransom most recently was VP of biology at Novasite Pharmaceuticals. He has a Ph.D. in physiology from University of Texas, Southwestern Medical School. Genomics POOL Suzanne Mullins Gene Logic Fills Key Position Gene Logic, a Gaithersburg, Md.-based company offering genomics and toxicogenomics solutions to support drug discovery and development, has named Suzanne Mullins as VP of quality systems and regulatory compliance. Ms. Mullins most recently was with Shire Pharmaceuticals. Emerging POOL Dr. Michael L. Sabolinski NitroMed Promotes Chief Medical Officer NitroMed, an emerging pharmaceutical company in Lexington, Mass., has promoted Michael L. Sabolinski, M.D., to chief medical officer from senior VP, clinical development and regulatory affairs. Dr. Sabolinski came to NitroMed in 2002 from Organogenesis, where he served as president and CEO. He earned his M.D. from the State University of New York and his M.S. in biochemistry from New York University. Robert Terifay Arginox Appoints President and Chief Operating Officer Arginox Pharmaceuticals, an emerging specialty pharma company, has named Robert Terifay as president and chief operating officer. He is responsible for leading the Redwood City, Calif.-based company’s operations. He most recently served as a commercial leader at Synta Pharmaceuticals. He holds a B.S. in biology and chemistry from the University of Notre Dame and master’s of management in marketing and health-service management from Northwestern University’s Kellogg Graduate School. Association POOL John Chaffee Randall Johnson NCBC Hires Regional Directors The North Carolina Biotechnology Center (NCBC), Research Triangle Park, N.C., a nonprofit corporation that supports biotech research, business, and education, has named John Chaffee as director of the agency’s new office in Greenville, N.C. Mr. Chaffee, 53, previously served as an economic development executive at the Pitt County Development Commission. He has bachelor’s and master’s degrees in economic geography from the University of North Carolina at Chapel Hill. Additionally, Randall Johnson has been hired as director of the Southeastern office in Wilmington, N.C. He previously served as an economic development professional and biotech liaison for the City of Wilmington. He has a bachelor’s degree in psychology and an MBA from Wake Forest University’s Babcock Graduate School of Management. Agency POOL Brian Barry Patrick Boyce Tessa Hall Todd Juro Steve Lederman Patricia Morrissey Nancy Schwartz Kevin Stone Colleen Zester Tracy Zuto Interlink Expands Staff Interlink Healthcare Communications, an advertising/communications agency based in Lawrenceville, N.J., has made serveral staff moves. Brian Barry has been promoted to copywriter. Patrick Boyce has been hired as senior Web developer. Tessa Hall has rejoined Interlink as senior project director on the education planning and development team. Ms. Hall received the Rising Star award from the Healthcare Businesswomen’s Association in 2004. Todd Juro has been appointed multimedia specialist. His 15 years of experience include interactive multimedia, animation, and Website design and production. Steve Lederman has been promoted to VP and director of production services. He is responsible for day-to-day management of the agency’s multimedia group. Patricia Morrissey has been hired as a senior copywriter. Nancy Schwartz has been promoted to VP/account supervisor. Kevin Stone has been hired as VP/account supervisor. Colleen Zester has been named VP/account supervisor. Tracy Zuto has joined as a senior copywriter. Laura Bartmess Dr. Jeff Berg Nadine Fabish James Gillespie Mary Karlson Jeanine Koch Jason Lung Abelson-Taylor Makes Appointments Abelson-Taylor, a Chicago-based pharmaceutical advertising agency, has promoted Laura Bartmess to account director from senior account supervisor. Ms. Bartmess, who has been with the agency since 1997, has a B.A. in journalism from the University of Wisconsin at Madison. Jeff Berg, Ph.D., has been promoted to account director from senior account supervisor. Dr. Berg joined the agency in 2002. He holds a Ph.D. in pharmacology from the University of Minnesota School of Medicine. Nadine Fabish also has been promoted to account director from senior account supervisor. She joined the agency in 2002. Ms. Fabish has an MBA from the University of Chicago Graduate School of Business and a B.A. in chemistry, with honors, from Kenyon College. Additionally, Jeanine Koch has been promoted to account director from senior account supervisor. Ms. Koch, who has been with the agency for seven years, has a B.S. in public relations from Illinois State University James Gillespie has been hired as senior copywriter. Previously, he was senior copywriter for Topin & Associates. He has a B.A. in communication from Loyola University of Chicago. Mary Karlson has been hired as senior art director for the DTC Group’s interactive division. She previously spent six years operating her own design firm. She has a B.A. in design communications from MacCormac College. Jason Lung has been hired as senior art director. Most recently, he was creative director at the Jacobs Agency. He has a B.F.A. in visual communications from Kendall College of Art and Design. Christopher Dimmock Seidler Bernstein Appoints Brand Strategy VP Christopher Dimmock has been promoted to VP for brand strategy at Seidler Bernstein, a Cambridge, Mass.-based marketing communications agency specializing in healthcare and life sciences. He joined the agency in 2003. Darlene Dobry Deborah Hughes John Nosta Michael Parisi Teri Park Stacey Singer Anne Squadrito Michael Strassberg Frank Tirone Shaun Urban Michael Zilligen CommonHealth Agencies Hire and Promote CommonHealth, a healthcare-communications network and WPP Group company based in Parsippany, N.J., has promoted four senior staff members to presidents of their respective units and added staff in its shared-services department and individual agency units. Darlene Dobry has been named president of Carbon, Wayne, N.J. She previously was executive VP and director of client services. She has more than 18 years of experience across a wide variety of therapeutic categories. Adient, Wayne, N.J., has hired Deborah Hughes as VP, group creative director. Previously, Ms. Hughes was VP, group creative director, at Torre Lazur McCann. John Nosta has been appointed president of Noesis, Morristown, N.J. Mr. Nosta, who has more than 20 years of healthcare-advertising experience, has been promoted from general manager and chief creative officer. Michael Parisi has been promoted to president of Altum from his previous role as executive VP and general manager. A 14-year veteran of marketing, his leadership helped to launch Altum in 2005. Teri Park joins CommonHealth as VP of business development in the agency’s shared-services department. Most recently, she was at Access Worldwide as VP of business development in the area of medical education. CommonHealth has promoted Stacey Singer to managing partner. In this position, she joins the agency’s management team and coordinates its creative marketing talent and resources and fosters cross-company collaboration. Ms. Singer has been with CommonHealth for 17 years. She most recently served as president of HLS, a title she has retained. Anne Squadrito has joined Adient as VP, associate creative director. Most recently, she was at Torre Lazur McCann as an associate creative director. Solara, Parsippany, N.J., has hired Michael Strassberg as senior VP, enterprise lead, responsible for providing managed-markets consulting services. Frank Tirone has also joined the agency’s shared-services department as business intelligence analyst. Most recently, he worked for Fisher Scientific as a data warehouse manager. Shaun Urban has been appointed president of Solara. He previously served as the agency’s general manager. He has 10 years of industry experience on both the client and agency sides of the business. Michael Zilligen has been named senior VP, enterprise lead, at Solara. Dr. Michael Kodack Vivian Pagoulatos Advanced Clinical Communications Hires and Promotes Advanced Clinical Communications, Lambertville, N.J., has promoted Michael Kodack, Pharm.D., to president. Dr. Kodack has been with the medical-communications company since 1998 and most recently led the communications group as VP. He earned his Pharm.D. from the Philadelphia College of Pharmacy and Science. Vivian Pagoulatos has been hired as VP of account services, responsible for managing client relationships and growing existing business. She has an MBA in marketing from Farleigh Dickinson University and a B.S. in pharmacy from Rutgers College of Pharmacy. Colleen O’Kane Martha Welshans inChord Hires Leaders for Media Team inChord Communications, Westerville, Ohio, a healthcare communications company and a division of Ventiv Health, has named Colleen O’Kane senior VP and director of brand communications. She leads the consumer media planning capability for inChord. Ms. O’Kane has more than 30 years of experience, most recently as chief new media officer at Ten United. She holds a bachelor’s degree from The Queen’s University of Belfast. Martha Welshans has been named VP and director of media operations. Based at the agency’s New York office, Ms. Welshans leads inChord’s professional and consumer media planning and buying services. She previously served as a media consultant to Conectics, a division of CommonHealth. She has a bachelor’s degree from Lock Haven State College. Seth Quillin Ron Schulman GSW Adds Executives Seth Quillin has been named senior VP/group creative director at GSW Worldwide, Westerville, Ohio, a healthcare advertising agency and part of the inChord Communications division of Ventiv Health. He previously was national creative director at Gravity Design Studios. He has a bachelor’s degree from Columbus College of Art and Design. GSW also has hired Ron Schulman as senior VP/account services. With more than 20 years of experience in consumer branding and advertising, Mr. Schulman most recently was employed by J. Walter Thompson as senior partner, management director. He has a master’s degree in international management from Thunderbird. Eric Rivera Dawn Ronaldo Palio Communications Adds Staff Palio Communications, a full-spectrum advertising and communications agency based in Saratoga Springs, N.Y., has named Eric Rivera as VP/account director. Previously, he was VP of program development at Postgraduate Institute for Medicine. He holds a bachelor’s degree in business administration from Florida Atlantic University. Dawn Ronaldo has joined the agency as account executive. She comes to Palio from Spectrum Healthcare Communications where she was an account manager/program manager. She has a bachelor’s degree from Rutgers University. Stephanie Schroeder Corinth Hires Director of Media Relations Corinth Group Communications, a full-service media-relations and medical-education consulting company in New York, has named Stephanie Schroeder as director of media relations. She oversees Corinth’s consumer-directed healthcare clients. Ms. Schroeder most recently managed media relations for healthcare clients at Investor Relations Group. She has a B.A. in communications from Hunter College, City University of New York, and a J.D. from New York Law School. Cari Weisberg Flaum Partners Hires Creative Exec Flaum Partners, New York, has hired Cari Weisberg as chief marketing and creative officer of its new Three Bridges subsidiary, a specialty communications group. Ms. Weisberg brings more than 15 years of experience on both the client and agency sides of healthcare communications. Most recently, she was president of FEI Women’s Health. CRO POOL Dr. Tomislav Babic Dr. Richard Margolin i3 Research Makes Key Appointments i3 Research, Basking Ridge, N.J., the contract research organization of i3, has hired Tomislav Babic, M.D., Ph.D., as senior director of central nervous system international. He is designing i3’s training program in Parkinson’s disease, among his other responsibilities, and is located at the firm’s Maidenhead, England, office. He earned his medical degree from Medical University of Zagreb and received his Ph.D. in clinical pharmacology at the University of Zagreb’s Institute of Pharmacology. Richard Margolin, M.D., has been named senior director of CNS North America. Dr. Margolin is a visiting scholar in the laboratory of molecular neuroimaging, department of psychiatry, at UCLA’s David Geffen School of Medicine. He has an undergraduate degree from Harvard University and a medical degree from the University of California, Irvine. Dr. Dale B. Evans Omnicare Clinical Research Names CEO Omnicare Clinical Research, King of Prussia, Pa., has appointed Dale B. Evans, Ph.D., as CEO. He is responsible for leading the contract research organization’s worldwide operations. Previously, Dr. Evans served as president of PeriApproval & Geriatrics Research, a business unit of Omnicare Clinical Research, and as president of global business development and client relations. He has an M.S. in pharmacology from the University of Pittsburgh School of Medicine and a Ph.D. in pharmacology from Hahnemann Medical University. Joseph L. Herring Covance Elects New Chairman The board of directors for Covance, a comprehensive drug-development services company in Princeton, N.J., has elected Joseph L. Herring to serve as chairman. Mr. Herring continues to serve as Covance’s CEO. He has replaced Christopher A. Kuebler, who retired as chairman at the end of 2005. Since joining the company in September 1996 as corporate VP and general manager of North America early development, Mr. Herring has held positions of increasing responsibility. Before being promoted to CEO in January 2005, he had served as the company’s president and chief operating officer since November 2001. Medical-Education POOL Bill Romano Beam Institute Names Director Beam Institute, New York, has hired Bill Romano as director of educational services, responsible for working with commercial supporters of continuing medical education (CME) events. Beam Institute partners with educational providers, specialty societies, and industry to offer CME programs for healthcare professionals. Mr. Romano previously worked as senior director of client services for Thomson Medical Education. Joanne Rosenberg Scinexa Names Director of Operations Scinexa Medical Education Group, a medical-education company in Plainsboro, N.J., has appointed Joanne Rosenberg to the newly created role of director of operations. She is responsible for all facets of operations and ensuring that CME programs funded by grants from commercial supporters meet best-practices policies. Previously, Ms. Rosenberg served as the director of operations at Practicome Solutions. She has a B.S. from the State University of New York. Service POOL Sean Boudreault PreferredTime Appoints Account Manager PreferredTime, a Boston-based company offering a pharmaceutical rep coordination service, has hired Sean Boudreault as a direct sales account manager. He most recently served as the sales operation manager at Mirror Image Internet. He has a B.S. in business management from Norwich University. Jennifer Cotteleer Cardiocore Names CEO Jennifer Cotteleer has been named CEO of Cardiocore Lab, Bethesda, Md., a provider of centralized cardiac safety monitoring and analysis. Most recently, Ms. Cotteleer was chief operating officer for PharmaPros. She has a B.S. in symbolic systems and an M.S. in engineering-economic systems from Stanford University. She also has an M.Sc. in management from the London Business School. Kathy Lee Barbara Levine TNS Expands Business Development Team TNS Healthcare has hired Kathy Lee and Barbara Levine to its expanding business development team. A division of London-based TNS, TNS Healthcare provides market measurement, analysis, and insight. Ms. Lee serves as VP of business development, supporting the Specialty Healthcare Group. She comes to TNS Healthcare from GfK Market Measures, where she created and managed the specialty-markets division. She has a bachelor’s degree from Moore College of Art. Ms. Levine also has been named VP of business development. She joins TNS Healthcare from PharMetrics, where she was VP of customer development and sales. She has a bachelor’s degree from the University of Rochester and an M.S. from Harvard University’s School of Public Health. Technology POOL Jeff Bairstow Dendrite Appoints Executive VP Dendrite, Bedminster, N.J., a provider of pharmaceutical sales, marketing, clinical, and compliance solutions, has appointed Jeff Bairstow as executive VP and chief financial officer. He joins Dendrite from RelayHealth, where he was chief operating officer. He has a B.A. from Vanderbilt University and an MBA from Vanderbilt’s Owen School of Business. Jeff Brady Advanced Health Media Names President Jeff Brady has been appointed president of Advanced Health Media, a Union-N.J. based supplier of technology solutions for compliant pharmaceutical meetings, speaker programs, and healthcare professional interactions. He has been promoted from general manager and senior VP. In this new role, Mr. Brady oversees the firm’s growth strategy and business operations. He has an MBA from the Sloan School of Management at the Massachusetts Institute of Technology and a bachelor’s degree in industrial engineering from Purdue University. Todd A. Joron Perceptive Appoints General Manager Todd A. Joron has been named corporate VP and general manager of Perceptive Informatics, Waltham, Mass., a wholly owned subsidiary of Parexel International that provides technology products and services. He manages Perceptive’s global offerings. Mr. Joron most recently was VP and scientific director of the life-sciences software division of Management Science Associates. He has a bachelor’s degree in health sciences and a master’s degree in business administration. Please send your personnel announcements to [email protected].
